UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported):February 25, 2008
GTx, Inc.
(Exact name of Registrant as specified in its charter)
| | | | | |
| Delaware | | 005-79588 | | 62-1715807 |
| (State or other jurisdiction of | | (Commission | | (I.R.S. Employer |
| incorporation or organization) | | File Number) | | Identification No.) |
3 N. Dunlap Street
Van Vleet Building
Memphis, Tennessee 38163
(901) 523-9700
(Address, including zip code, of Registrant’s principal executive offices
Registrant’s telephone number, including area code)
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
ITEM 8.01Other Events.
On February 25, 2008, GTx, Inc. issued a press release announcing positive Phase III clinical trial results for toremifene citrate 80 mg, the Company’s investigational therapy for the treatment of multiple side effects of androgen deprivation therapy (ADT) for advanced prostate cancer, a copy of which is furnished as Exhibit 99.1 to this Current Report.
ITEM 9.01Financial Statements and Exhibits.
(c) Exhibits
| | | | | |
| Exhibit | | |
| Number | | Description |
| | 99.1 | | | Press Release issued by GTx, Inc. dated February 25, 2008 |
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| | | | | |
| | GTx, Inc.
| |
| Date: February 25, 2008 | By: | /s/ Henry P. Doggrell | |
| | | Name: | Henry P. Doggrell | |
| | | Title: | Vice President, General Counsel/Secretary | |
